Background: Intraoperative hypovolemic phlebotomy (HP) has been suggested to reduce central venous pressure (CVP) before hepatectomy. This study aimed to analyze the impact of CVP drop after HP on intraoperative blood loss and postoperative renal function.

Methods: A retrospective review of a prospective database including 100 consecutive patients (43 males and 57 females; mean age, 65 years; range 23-89 years) undergoing liver resection with HP was performed. The primary outcome variable was estimated blood loss (EBL), and the secondary outcome was postoperative serum creatinin (Scr). A multivariate linear regression analysis was performed to identify predictors of intraoperative blood loss.

Results: The median CVP before blood salvage was 8 mmHg (range 4-30 mmHg). The median volume of hypovolemic phlebotomy was 400 ml (range 200-1000 ml). After HP, CVP decreased to a median of 3 mmHg (range -2 to 16 mmHg), resulting in a median CVP drop of 5.5 mmHg (range 2-14 mmHg). The median EBL during liver resection was 165 ml (range 0-800 ml). The median preoperative serum creatinin (Scr) was 0.82 g/dl (range 0.5-1.74 g/dl), and the postoperative Scr on day 1 was 0.74 g/dl (range 0.44-1.68 g/dl). The CVP drop was associated with EBL (P < 0.001). There was no significant impact of CVP drop on postoperative Scr.

Conclusion: A CVP drop after HP is a strong independent predictor of EBL during liver resection. The authors advocate the routine use of HP to reduce perioperative blood loss and transfusion rates in liver surgery. As a predictive tool, CVP drop might help surgeons decide whether a laparoscopic approach is safe.

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5737-7DOI Listing

Publication Analysis

Top Keywords

hypovolemic phlebotomy
12
intraoperative blood
12
blood loss
12
liver resection
12
cvp drop
12
central venous
8
venous pressure
8
range
8
serum creatinin
8
creatinin scr
8

Similar Publications

Hypovolaemic phlebotomy to reduce the need for perioperative transfusion: a price worth paying?

Lancet Gastroenterol Hepatol

December 2024

Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, 44892 Bochum, Germany. Electronic address:

View Article and Find Full Text PDF

Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial.

Lancet Gastroenterol Hepatol

December 2024

Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Canadian Blood Services, Ottawa, ON, Canada.

Background: Blood loss and subsequent red blood cell transfusions are common in liver surgery. Hypovolaemic phlebotomy is associated with decreased red blood cell transfusion in observational studies. This trial aimed to investigate whether hypovolaemic phlebotomy is superior to usual care in reducing red blood cell transfusions in patients undergoing liver resection.

View Article and Find Full Text PDF
Article Synopsis
  • Large-volume therapeutic phlebotomy is the main treatment for hemochromatosis and allows researchers to study blood flow changes during low blood volume conditions.
  • A 64-year-old male patient with hemochromatosis underwent 1000 mL phlebotomy on nine occasions, during which he was closely monitored for vital signs and tolerance.
  • The study found that the patient successfully maintained blood pressure through increased heart rate and vascular resistance, indicating that this phlebotomy method can safely model blood loss scenarios in clinical settings.
View Article and Find Full Text PDF

Introduction: Blood loss and red blood cell (RBC) transfusion in liver surgery are areas of concern for surgeons, anesthesiologists, and patients alike. While various methods are employed to reduce surgical blood loss, the evidence base surrounding each intervention is limited. Hypovolemic phlebotomy, the removal of whole blood from the patient without volume replacement during liver transection, has been strongly associated with decreased bleeding and RBC transfusion in observational studies.

View Article and Find Full Text PDF

WHEN AND HOW TO USE ORTHOSTATIC VITAL SIGNS.

J Emerg Med

September 2022

Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

Background: Much controversy surrounds the use of orthostatic vital signs (OVS), including their indications, performance, and interpretation. This can lead to conflict between nurses, physicians, and consultants. This article summarizes the evidence for OVS in selected emergency department (ED) indications and the basis for a rapid measurement protocol.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!